Healthcare Sectors Update-Time to Review Your Portfolio…Update-1
Update-1 11/18...Healthcare stocks had a good week with the XLV up almost 1% to $134 despite choppiness. We are still facing MACRO headwinds and the FED so stay cautious. There was good tape action in mid-cap biopharmas. Medtech is looking better with the IHI up 4% for the week but the sector...
We are Back Online, Updates Coming 11/15
Raygent is back online. We'll try to get updates to you in coming days. Both the IBB and XBI are up about 5% over the past five days. The XLV is weaker due to weakness in UNH.
Epic Pacific Storms of 2022-24 Season. Update- BOMB CYCLONE NOV 2024
Bomb Cyclone hits Northwest Coast CA and OR Record-setting bomb cyclone, intense as a hurricane, lashes Northwest https://www.washingtonpost.com/weather/2024/11/19/atmospheric-river-bomb-cyclone-california-low-pressure/ A record-strong low-pressure system will steer an atmospheric river into...
Biotech Stocks Ruffled During FedSpeak Week..Update-1
Update-1 Nov. 8..Volatile election day favors the bulls. IBB and XBI both up over 1%. TSY yields down and dollar down. UNH up 1.48%, Junior metals are hot with gold and silver. Crypto spat rattles markets. Amgen (AMGN) leads the way up over 5% to $290 level a record high. New clinical dat...
Can Biotech Stocks Continue Rallying in this Bear Market?…Update-2
Update 2..-11/3...Powell curbs enthusiasm for stocks with harsh rhetoric. Get whipsawed? We get it, rates are going up Recent trades: bought HOLX, sold MRNA, bought more IHI. Biotech movers: BMY up 1.39%, LLY up 1.96%, ROIV up 6.655, VCYT up 24.25%. Veracyte grows revenue 25% to $75.6M. IBB...